Predict your next investment

HEALTHCARE | Biotechnology
spinifexpharma.com

See what CB Insights has to offer

Total Raised

$75.18M

Investors Count

7

Deal Terms

3

Spinifex Funding, Spinifex Valuation & Spinifex Revenue

4 Fundings

Spinifex's latest funding round was a Acquired for on June 29, 2015.

Spinifex's valuation in September 2008 was $34.84M.

Spinifex's latest post-money valuation is from June 2015.

Sign up for a free 30-day trial to see Spinifex's valuations in June 2015 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/29/2015

Acquired

$99M

$0.00B

((9.99x))

FY 1234

2

4/11/2014

Series C

$99M

$0.00B

((9.99x))

FY 1234

10

8/23/2011

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

9/4/2008

Series A

$99M

$34.84M

$0.00B

((9.99x))

FY 1234

10

Date

6/29/2015

4/11/2014

8/23/2011

9/4/2008

Round

Acquired

Series C

Series B

Series A

Amount

$99M

$99M

$99M

Investors

Valuation

$99M

$34.84M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

2

10

10

10

Spinifex Deal Terms

3 Deal Terms

Spinifex's deal structure is available for 3 funding rounds, including their Acquired from June 29, 2015.

Round

Acquired

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

Series A

Spinifex Investors

7 Investors

Spinifex has 7 investors. Novartis invested in Spinifex's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/29/2015

6/29/2015

1
Acquired

Corporation

Switzerland

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Australia

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Academic/University

Australia

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Australia

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

California

First funding

6/29/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

6/29/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Type

Corporation

Venture Capital

Academic/University

Venture Capital

Venture Capital

Location

Switzerland

Australia

Australia

Australia

California

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.